Cost-utility analysis of Immuno-Oncotherapy in chemotherapy-pretreated, recurrent, non-small cell lung cancer in Thailand
Doctor of Philosophy (Health Sciences), 2023
Saved in:
Main Author: | Geater, Sarayut L. |
---|---|
Other Authors: | Paramee Thongsuksai |
Format: | Theses and Dissertations |
Language: | English |
Published: |
Prince of Songkla University
2023
|
Subjects: | |
Online Access: | http://kb.psu.ac.th/psukb/handle/2016/19258 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Prince of Songkhla University |
Language: | English |
Similar Items
-
Chemotherapy in non-small cell lung cancer: opportunities for advancement
by: Akhtari, M, et al.
Published: (2020) -
The role of monoclonal antibody in combination with first-line chemotherapy in Asian patients with advanced non-small cell lung cancer
by: Cho, B.C., et al.
Published: (2014) -
Non-small cell lung cancer presenting with neoplastic fever at diagnosis and relapse
by: Zee, Y.K., et al.
Published: (2014) -
The Impact of Thailand’s Universal Coverage Scheme on Household Catastrophic Health Expenditure
by: Meemon, Natthani, et al.
Published: (2019) -
Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients
by: Millward, M.J., et al.
Published: (2016)